These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 30253922)
1. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession. Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922 [TBL] [Abstract][Full Text] [Related]
2. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo. Yang Q; Ji G; Li J Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760 [TBL] [Abstract][Full Text] [Related]
3. Six-transmembrane epithelial antigen of the prostate 1 expression promotes ovarian cancer metastasis by aiding progression of epithelial-to-mesenchymal transition. Jiao Z; Huang L; Sun J; Xie J; Wang T; Yin X; Zhang H; Chen J Histochem Cell Biol; 2020 Aug; 154(2):215-230. PubMed ID: 32382787 [TBL] [Abstract][Full Text] [Related]
4. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland. Maia CJ; Socorro S; Schmitt F; Santos CR Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632 [TBL] [Abstract][Full Text] [Related]
5. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos. Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353 [TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
7. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway. Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474 [TBL] [Abstract][Full Text] [Related]
8. High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer. Li Y; Qin J; Wu J; Dai X; Xu J Breast Cancer Res Treat; 2020 Jul; 182(1):35-46. PubMed ID: 32424721 [TBL] [Abstract][Full Text] [Related]
9. Markers of progression and invasion in short term follow up of untreated breast cancer patients. Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416 [TBL] [Abstract][Full Text] [Related]
10. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation. Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469 [TBL] [Abstract][Full Text] [Related]
11. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer. Li Y; Su X; Pan H Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011 [TBL] [Abstract][Full Text] [Related]
13. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion. Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis. Lee CH; Chen SL; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chiou YH; Chen CY; Lin CY; Chen ML; Chen CJ Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104516 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic analyses of the significance of STEAP1 and STEAP2 in lung cancer. Liu T; Niu X; Li Y; Xu Z; Chen J; Xu G World J Surg Oncol; 2022 Mar; 20(1):96. PubMed ID: 35346237 [TBL] [Abstract][Full Text] [Related]
16. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression. Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922 [TBL] [Abstract][Full Text] [Related]
17. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas. Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206 [TBL] [Abstract][Full Text] [Related]
18. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer. Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980 [TBL] [Abstract][Full Text] [Related]
19. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer. Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667 [TBL] [Abstract][Full Text] [Related]
20. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance. Yin Y; Sanders AJ; Jiang WG Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]